fingolimod hydrochloride has been researched along with trinitrobenzenesulfonic acid in 2 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (trinitrobenzenesulfonic acid) | Trials (trinitrobenzenesulfonic acid) | Recent Studies (post-2010) (trinitrobenzenesulfonic acid) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 2,710 | 10 | 1,042 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Benson, EL; Heuvelman, DM; Masferrer, JL; Radi, ZA | 1 |
Abdollahi, M; Baeeri, M; Ghafour-Broujerdi, E; Gholami, M; Hassani, S; Mousavi, T; Rahimifard, M; Vakhshiteh, F | 1 |
2 other study(ies) available for fingolimod hydrochloride and trinitrobenzenesulfonic acid
Article | Year |
---|---|
Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12/23p40 in a TNBS-induced Crohn's disease model.
Topics: Animals; Antibodies, Monoclonal; Crohn Disease; Diarrhea; Disease Models, Animal; Female; Fingolimod Hydrochloride; Gastrointestinal Agents; Interleukin-12; Interleukin-23; Mice; Mice, Inbred BALB C; Organ Size; Propylene Glycols; Sphingosine; Sulfasalazine; Trinitrobenzenesulfonic Acid; Weight Loss | 2011 |
Comparison of the safety and efficacy of fingolimod and tofacitinib in the zebrafish model of colitis.
Topics: Animals; Colitis; Fingolimod Hydrochloride; Inflammatory Bowel Diseases; Myeloid Differentiation Factor 88; Trinitrobenzenesulfonic Acid; Zebrafish | 2022 |